HDAC6 and myeloid sarcoma: HDAC6 human brain mapping with [18F] Bavarostat as a radiotracer has been proposed [156] and could be added to serum-based biomarkers to define MS types based on neurodegeneration, subgrouping MS into those patients with early or late neurodegeneration.